Navigation Links
Leap in leukemia treatment reported by Dartmouth researchers
Date:5/13/2013

Doctors at Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC) have found a combination of drugs to potentially treat chronic lymphocytic leukemia (CLL) more effectively. The research was published online on May 3, 2013, and it will appear as a letter in the journal Leukemia, a publication of the prestigious Nature Publishing Group. The study helps address a basic problem of treating CLL.

CLL lives both in the blood in circulation, and in lymph nodes and bone marrow. The former is relatively easy to kill, but the disease recurs because of resistant CLL cells in the lymph nodes and bone marrow. The researchers found an innovative drug combination that targets the stubborn CLL cells.

"We have been studying the mechanism in the cancer cells that causes the resistance to treatment," says Alan Eastman, the senior researcher on the team and a professor of pharmacology and toxicology at the Geisel School of Medicine at Dartmouth, "and that in turn, led us to find drugs that target the resistance." Eastman led the team at Dartmouth-Hitchcock's Norris Cotton Cancer Center that also included Ryan Soderquist, Darcy Bates, and Alexey Danilov.

The researchers found a very effective drug combination of gossypol plus navitoclax to kill CLL cells. "Both drugs have been given to patients, but never in combination, because no one had the mechanistic rationale for doing that. Now we have what we think is the most promising drug combination so far for the treatment of CLL," says Eastman.

CLL cells in the lymph nodes have an increased level of a protein known as BCL-X. Gossypol likely inhibits this protein, which allows the navitoclax to work more effectively to kill the cancer cells. Eastman and his team tested this drug combination on CLL immediately after they came out of the patients.

The willingness of the patients to participate was integral to this study," Eastman adds. "After 40 years of research, I think this is the most promising idea I have had that might truly impact patient outcome." The researchers hope a clinical trial will soon follow.


'/>"/>

Contact: Robin Dutcher
robin.dutcher@hitchcock.org
603-653-9056
Dartmouth-Hitchcock Medical Center
Source:Eurekalert

Related medicine news :

1. Gene Discovery May Offer Breakthrough for Rare Leukemia
2. Endometrial and acute myeloid leukemia cancer genomes characterized
3. Soaring Prices Keep Leukemia Drugs From Patients, Experts Say
4. Leading leukemia experts: High leukemia treatment costs may be harming patients
5. New drug combination therapy developed to treat leukemia
6. Molecule treats leukemia by preventing cancer cell repair, Jackson Laboratory scientists report
7. Key bone marrow protein identified as potential new leukemia treatment target
8. Royal Flush Havanese's Facebook Page Hits 500 Likes Prompting Owner To Donate $500 To The Leukemia And Lymphoma Society
9. T-cell therapy eradicates an aggressive leukemia in 2 children
10. Immune Therapy Shows Early Promise for Advanced Leukemia
11. Gene Mutations Appear Key to Childhood Leukemia Risk, Study Says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... TIME for Kids and The ZAC ... a new partnership to reach nearly 1 million children with important water safety messages ... is the leading cause of accidental death in children one to 6 years of ...
(Date:5/5/2016)... ... 05, 2016 , ... The 2016 Nike Soccer Camp will be directed by ... coaching staff. Together they bring their winning Vandals coaching philosophy to young athletes. Programs ... 5-13, and high school players. Session dates are as follows: , Youth Day Camp ...
(Date:5/5/2016)... ... May 05, 2016 , ... United Collection Bureau, Inc. (UCB) announces ... more than 15 years of experience within the healthcare revenue cycle industry. With a ... the Director of Patient Financial Services at Spectrum Health. While at Spectrum Health, Clark ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... honored finalists and winners Tuesday evening, May 3, at the 2016 ISE® Central ... , Scott Pettigrew, Vice President and Chief Security Officer of HMS, was selected ...
(Date:5/5/2016)... ... May 05, 2016 , ... ACLS Certification Institute, a ... new referral program, giving participants incentive for spreading the word about the Institute’s ... know many professionals share resources with their friends and colleagues,” said Vonda Andrews, ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... NEW YORK , May 4, 2016 ... Size, Share, Development, Growth and Demand Forecast to 2022 - ... End User (Hospital, Diagnostic Center and Others)" by P&S Market ... at $4,894.3 million in 2015, and it is expected to ... slice type, the high slice type segment is expected to ...
(Date:5/4/2016)... May 4, 2016 ... the  "Global Multiple Myeloma Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... and Competitive Landscape Highlights 2016, provides comprehensive ... Myeloma epidemiology, Multiple Myeloma market valuations and ...
(Date:5/4/2016)... May 4, 2016 ... the  "Global Acute lymphocytic Leukemia Market and ... their offering.       (Logo: ... Lymphocytic Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Lymphocytic Leukemia epidemiology, ...
Breaking Medicine Technology: